Literature DB >> 8213810

Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome.

A McConkie-Rosell1, A M Lachiewicz, G A Spiridigliozzi, J Tarleton, S Schoenwald, M C Phelan, P Goonewardena, X Ding, W T Brown.   

Abstract

DNA at the FMR-1 locus was analyzed by Southern blot using probe StB12.3 in an unusual fragile X family with six brothers, three of whom are affected with fragile X to varying degrees, two of whom are nonpenetrant carriers, and one of whom is unaffected. Fragile X chromosome studies, detailed physical examinations, and psychological testing were completed on all six. Two of the affected brothers and the two nonpenetrant brothers were found to be methylation mosaics. The three affected males spanned the phenotypic and cognitive spectrum of the fragile X syndrome. A correlation was seen between the degree of methylation and the phenotypic expression identified in the three affected males. The two males initially classified as nonpenetrant were found to have mild phenotypic expression which consisted of minor cognitive deficits and a partial physical phenotype. These two, who were negative on fragile X chromosome studies, were found on DNA analysis to have large broad smears, with approximately 97% of the DNA unmethylated. The results described here indicate that some "nonpenetrant" carrier males may have varying amounts of methylation of the FMR-1 region, which can result in mild expression of the fragile X syndrome. The apparently mild phenotypic and cognitive expression of the fragile X syndrome in the two males, initially classified as nonpenetrant, who are mosaic for hypermethylation of an expansion of the CGG repeat in the premutation range, indicates that expression of the syndrome is not confined to males with large, hypermethylated expansions (full mutation) but has instead a gradient effect with a threshold for the full expression of the phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213810      PMCID: PMC1682375     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  X-linked mental retardation: transmission of the trait by an apparently unaffected male.

Authors:  G Wolff; H Hameister; H H Ropers
Journal:  Am J Med Genet       Date:  1978

2.  Phenotypic variation in male-transmitted fragile X: genetic inferences.

Authors:  D Z Loesch; D A Hay; G R Sutherland; J Halliday; C Judge; G C Webb
Journal:  Am J Med Genet       Date:  1987-06

3.  A rapid banding technique for human chromosomes.

Authors:  M Seabright
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

4.  Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island.

Authors:  D Heitz; F Rousseau; D Devys; S Saccone; H Abderrahim; D Le Paslier; D Cohen; A Vincent; D Toniolo; G Della Valle
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

5.  Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis.

Authors:  A Vincent; D Heitz; C Petit; C Kretz; I Oberlé; J L Mandel
Journal:  Nature       Date:  1991-02-14       Impact factor: 49.962

6.  Learning disabilities and attentional problems in boys with the fragile X syndrome.

Authors:  R Hagerman; M Kemper; M Hudson
Journal:  Am J Dis Child       Date:  1985-07

7.  Further segregation analysis of the fragile X syndrome with special reference to transmitting males.

Authors:  S L Sherman; P A Jacobs; N E Morton; U Froster-Iskenius; P N Howard-Peebles; K B Nielsen; M W Partington; G R Sutherland; G Turner; M Watson
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  The fragile X syndrome in a large family. II. Psychological investigations.

Authors:  H Veenema; T Veenema; J P Geraedts
Journal:  J Med Genet       Date:  1987-01       Impact factor: 6.318

9.  Fragile sites in human chromosomes II: demonstration of the fragile site Xq27 in carriers of X-linked mental retardation.

Authors:  P N Howard-Peebles
Journal:  Am J Med Genet       Date:  1980

10.  FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.

Authors:  T W Glover
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

View more
  40 in total

Review 1.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

2.  FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.

Authors:  Lorena Santa María; Solange Aliaga; Víctor Faundes; Paulina Morales; Ángela Pugin; Bianca Curotto; Paula Soto; M Ignacia Peña; Isabel Salas; M Angélica Alliende
Journal:  Genet Res (Camb)       Date:  2016-06-28       Impact factor: 1.588

3.  Evidence for genetic anticipation in nodal osteoarthritis.

Authors:  G D Wright; M Regan; C M Deighton; G Wallis; M Doherty
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

4.  Don't miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation.

Authors:  Edda Haberlandt; Sibylle Zotter; Martina Witsch-Baumgartner; Johannes Zschocke; Dieter Kotzot
Journal:  Eur J Pediatr       Date:  2014-07-17       Impact factor: 3.183

5.  Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats.

Authors:  D Wöhrle; U Salat; D Gläser; J Mücke; M Meisel-Stosiek; D Schindler; W Vogel; P Steinbach
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

Review 6.  Variable FMR1 gene methylation of large expansions leads to variable phenotype in three males from one fragile X family.

Authors:  B B de Vries; C C Jansen; A A Duits; C Verheij; R Willemsen; J O van Hemel; A M van den Ouweland; M F Niermeijer; B A Oostra; D J Halley
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

7.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.

Authors:  F Rousseau; D Heitz; J Tarleton; J MacPherson; H Malmgren; N Dahl; A Barnicoat; C Mathew; E Mornet; I Tejada
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

8.  C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.

Authors:  Elaine Y Liu; Jenny Russ; Kathryn Wu; Donald Neal; Eunran Suh; Anna G McNally; David J Irwin; Vivianna M Van Deerlin; Edward B Lee
Journal:  Acta Neuropathol       Date:  2014-05-08       Impact factor: 17.088

9.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.

Authors:  Jessica Ezzell Hunter; Michael P Epstein; Stuart W Tinker; Krista H Charen; Stephanie L Sherman
Journal:  Genet Epidemiol       Date:  2008-09       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.